Sense Biodetection Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
32
- Latest Deal Type
-
M&A
Sense Biodetection General Information
Description
Developer of user-centered diagnostic equipment designed to improve treatment and assist in decision-making in a decentralized healthcare system. The company's equipment includes point-of-care diagnostic tests that use molecular methods to a polymerase chain reaction (PCR) through fluid handling and temperature control, enabling clinics and medical professionals to detect infection and make treatment decisions immediately.
Contact Information
Website
www.sense-bio.com(Operating Subsidiary)
Corporate Office
- 29 and 30 The Quadrant
- Abingdon Science Park
- Abingdon OX14 3YS
- England, United Kingdom
Corporate Office
- 29 and 30 The Quadrant
- Abingdon Science Park
- Abingdon OX14 3YS
- England, United Kingdom
Sense Biodetection Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 01-Feb-2023 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series B) | 17-Nov-2021 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A) | 29-Oct-2019 | Completed | Generating Revenue | |||
| 6. Grant | 23-Apr-2018 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2017 | Completed | Startup | |||
| 4. Grant | 01-Dec-2016 | Completed | Startup | |||
| 3. Grant | Completed | Startup | ||||
| 2. Seed Round | 08-Jun-2016 | $738K | $738K | Completed | Startup | |
| 1. Grant | 01-May-2015 | $257K | Completed | Startup |
Sense Biodetection Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| C2 Preferred | ||||||||
| C1 Preferred | ||||||||
| B2 Preferred Shares | ||||||||
| B2 Preferred Shares | ||||||||
| B1 Preferred Shares | ||||||||
| A Ordinary | 24,875 | $0.001361 | $16.2 | $16.2 | 1x | $16.2 | 4.96% | |
| A Ordinary | 19,153 | $0.001361 | $15.12 | $15.12 | 1x | $15.12 | 3.82% |
Sense Biodetection Comparisons
Industry
Financing
Details
Sense Biodetection Competitors (21)
One of Sense Biodetection’s 21 competitors is Hain Lifescience, a Corporate Backed or Acquired company based in Nehren, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hain Lifescience | Corporate Backed or Acquired | Nehren, Germany | ||||
| New World Technologies | Corporation | New York, NY | ||||
| Visby Medical | Venture Capital-Backed | San Jose, CA | ||||
| Lucira Health | Formerly VC-backed | Emeryville, CA | ||||
| Trivitron Healthcare | Formerly PE-Backed | Chennai, India |
Sense Biodetection Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sense Biodetection Patents
Sense Biodetection Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D959693-S1 | Diagnostic test device | Active | 31-Mar-2021 | ||
| GB-202013354-D0 | Devices | Inactive | 26-Aug-2020 | ||
| GB-202013353-D0 | Devices | Inactive | 26-Aug-2020 | ||
| GB-202013358-D0 | Devices | Inactive | 26-Aug-2020 | ||
| GB-202013361-D0 | Devices | Inactive | 26-Aug-2020 |
Sense Biodetection Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sense Biodetection Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angels in Med City | Angel Group | Minority | ||
| Blueray Capital | Lender/Debt Provider | Minority | ||
| Cambridge Innovation Capital | Venture Capital | Minority | ||
| Department of Health of UK | Corporation | |||
| Earlybird Venture Capital | Venture Capital | Minority |
Sense Biodetection FAQs
-
When was Sense Biodetection founded?
Sense Biodetection was founded in 2014.
-
Where is Sense Biodetection headquartered?
Sense Biodetection is headquartered in Abingdon, United Kingdom.
-
What is the size of Sense Biodetection?
Sense Biodetection has 32 total employees.
-
What industry is Sense Biodetection in?
Sense Biodetection’s primary industry is Diagnostic Equipment.
-
Is Sense Biodetection a private or public company?
Sense Biodetection is a Private company.
-
What is Sense Biodetection’s current revenue?
The current revenue for Sense Biodetection is .
-
How much funding has Sense Biodetection raised over time?
Sense Biodetection has raised $105M.
-
Who are Sense Biodetection’s investors?
Angels in Med City, Blueray Capital, Cambridge Innovation Capital, Department of Health of UK, and Earlybird Venture Capital are 5 of 11 investors who have invested in Sense Biodetection.
-
Who are Sense Biodetection’s competitors?
Hain Lifescience, New World Technologies, Visby Medical, Lucira Health, and Trivitron Healthcare are some of the 21 competitors of Sense Biodetection.
-
When was Sense Biodetection acquired?
Sense Biodetection was acquired on 01-Feb-2023.
-
Who acquired Sense Biodetection?
Sense Biodetection was acquired by Sherlock Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
